GlaxoSmithKline PLC Total Voting Rights (2553B)
January 05 2015 - 4:00AM
UK Regulatory
TIDMGSK
RNS Number : 2553B
GlaxoSmithKline PLC
05 January 2015
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with Disclosure and Transparency Rule 5.6.1R,
GlaxoSmithKline plc (the 'Company') hereby notifies the market of
the following:
The Company's issued share capital as at 31 December 2014
consisted of 5,355,297,232 Ordinary Shares of 25p each, of which
491,515,950 Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is
4,863,781,282. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure and Transparency Rules.
V A Whyte
Company Secretary
5 January 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRUGUBAGUPAURA
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024